Xuebijing Injection (血必净注射液) increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns
Back to article page
OriginalPaper|Updated:2021-08-27
|
Xuebijing Injection (血必净注射液) increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns
Xuebijing Injection (血必净注射液) increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns
中国结合医学杂志(英文版)2017年23卷第9期 页码:703-708
Affiliations:
1. Medical School of Chinese PLA, Chinese PLA General Hospital,Beijing,China
2. Chinese People’s Armed Police Force Academy,Hebei Province,Langfang,China
3. Research Department, the Tianjin Chase Sun Pharmaceutical Co., Ltd.,Tianjin,China
4. Department of Pathology, Langfang Traditional Chinese Medicine Hospital,Hebei Province,Langfang,China
5. Department of Traditional Chinese Medicine, Chinese PLA General Hospital,Beijing,China
6. Burns Institute, First Hospital Affiliated to PLA General Hospital,Beijing,China
Author bio:
Funds:
Supported by the National Natural Science Foundation of China (No. 81471872);Conflict of Interests;The authors declare that they have no conflict of interests.;Author Contributions;Dai YL and Hu S designed the experiments. Li JY, Bai HY and Liu S provided technical support. Dai YL, Bai HY, Dou YQ and Hu S conducted the experiments. Dai YL and Dou YQ performed the analysis drafted the manuscript. All authors read and approved the final version of the manuscript.
Dai, Yl., Li, Jy., Bai, Hy. et al. Xuebijing Injection (血必净注射液) increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns., Chin. J. Integr. Med. 23, 703–708 (2017). https://doi.org/10.1007/s11655-017-2407-y
Yue-long Dai, Jing-yuan Li, Hui-ying Bai, et al. Xuebijing Injection (血必净注射液) increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns[J]. Chinese Journal of Integrative Medicine, 2017,23(9):703-708.
Dai, Yl., Li, Jy., Bai, Hy. et al. Xuebijing Injection (血必净注射液) increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns., Chin. J. Integr. Med. 23, 703–708 (2017). https://doi.org/10.1007/s11655-017-2407-yDOI:
Yue-long Dai, Jing-yuan Li, Hui-ying Bai, et al. Xuebijing Injection (血必净注射液) increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns[J]. Chinese Journal of Integrative Medicine, 2017,23(9):703-708. DOI: 10.1007/s11655-017-2407-y.
Xuebijing Injection (血必净注射液) increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns
摘要
To investigate the effects of Xuebijing Injection (血必净注射液
XBJ) on survival rate and pulmonary vasopermeability in a rat model of severe scald injury. Rats were divided into two experiments: experiment 1 was monitored for 12 h post-injury for survival analysis after severe burns; in experiment 2
rats were killed for determination of pulmonary vascular permeability and pro-inflflammatory mediators. In both experiments
rats were subject to third-degree 50% total body surface area (TBSA) burns or sham injury followed by XBJ or normal saline (NS) treatment. In addition
rat pulmonary microvascular endothelium cells (PMECs) were pretreated with either XBJ or phosphate buffer saline (PBS)
and then subjected to sham serum or scald serum stimulation for 2 or 6 h
followed by transwell examination for the permeability of PMECs. Meanwhile
pro-inflflammatory mediators in PMECs culture supernatant were also investigated. The average survival time in the scald+XBJ group was 582.1±21.2 min
which was signifificantly longer than that in the scald + NS group (345.8±25.4 min
P<0.01). Plasma levels of tumor necrosis factor-alpha (TNF-α)
E-selectin
interleukin-6 (IL-6)
vascular permeability and water content of lung tissues were signifificantly increased in animals after severe burns (P<0.01). However
administration of XBJ signifificantly decreased these levels in plasma and lung tissue. In in vitro cell experiments
XBJ markedly attenuated permeability in PMECs monolayer and reduced the levels of TNF-α
IL-6 and soluble E-selectin after stimulation with scald serum (P<0.01). XBJ increases early survival rate by alleviating pulmonary vasopermeability and inhibiting pro-inflflammatory mediators in rats subjected to lethal scald injury. XBJ may be a potent drug in treatment of severe burns.
Abstract
To investigate the effects of Xuebijing Injection (血必净注射液
XBJ) on survival rate and pulmonary vasopermeability in a rat model of severe scald injury. Rats were divided into two experiments: experiment 1 was monitored for 12 h post-injury for survival analysis after severe burns; in experiment 2
rats were killed for determination of pulmonary vascular permeability and pro-inflflammatory mediators. In both experiments
rats were subject to third-degree 50% total body surface area (TBSA) burns or sham injury followed by XBJ or normal saline (NS) treatment. In addition
rat pulmonary microvascular endothelium cells (PMECs) were pretreated with either XBJ or phosphate buffer saline (PBS)
and then subjected to sham serum or scald serum stimulation for 2 or 6 h
followed by transwell examination for the permeability of PMECs. Meanwhile
pro-inflflammatory mediators in PMECs culture supernatant were also investigated. The average survival time in the scald+XBJ group was 582.1±21.2 min
which was signifificantly longer than that in the scald + NS group (345.8±25.4 min
P<0.01). Plasma levels of tumor necrosis factor-alpha (TNF-α)
E-selectin
interleukin-6 (IL-6)
vascular permeability and water content of lung tissues were signifificantly increased in animals after severe burns (P<0.01). However
administration of XBJ signifificantly decreased these levels in plasma and lung tissue. In in vitro cell experiments
XBJ markedly attenuated permeability in PMECs monolayer and reduced the levels of TNF-α
IL-6 and soluble E-selectin after stimulation with scald serum (P<0.01). XBJ increases early survival rate by alleviating pulmonary vasopermeability and inhibiting pro-inflflammatory mediators in rats subjected to lethal scald injury. XBJ may be a potent drug in treatment of severe burns.
关键词
Xuebijing Injectionburn injuryvasopermeabilityendothelial cellshypovolemic shockChinese Medicine
Keywords
Xuebijing Injectionburn injuryvasopermeabilityendothelial cellshypovolemic shockChinese Medicine
Orbegozo Cortes D, Santacruz C, Donadello K, Nobile L, Taccone FS. Colloids for fluid resuscitation: what is their role in patients with shock? Minerva Anestesiol 2014;80:963–969.
Luo HM, Hu S, Bai HY, Wang HB, Du MH, Lin ZL, et al. Valproic acid treatment attenuates caspase-3 activation and improves survival after lethal burn injury in a rodent model. J Burn Care Res 2014;35:e93–98.
Evers LH, Bhavsar D, Mailander P. The biology of burn injury. Exp Dermatol 2010;19:777–783.
Sakurai H, Nozaki M, Traber LD, Hawkins HK, Traber DL. Microvascular changes in large flame burn wound in sheep. Burns 2002;28:3–9.
Xu Q, Liu J, Guo X, Tang Y, Zhou G, Liu Y, et al. Xuebijing Injection reduces organ injuries and improves survival by attenuating inflammatory responses and endothelial injury in heatstroke mice. BMC Complement Altern Med 2015;15:4.
Fang K, Wang XL. Treatment of multiple organ dysfunction syndrome by Xuebijing Injection. Chin J Integr Tradit West Med (Chin) 2013;33:205–207.
Ikezu T, Okamoto T, Yonezawa K, Tompkins RG, Martyn JA. Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J Biol Chem 1997;272:25289–25295.
Chen SF, Fei X, Li SH. A new simple method for isolation of microvascular endothelial cells avoiding both chemical and mechanical injuries. Microvasc Res 1995;50:119–128.
Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care 2009;13:R183.
Hu S, Hou JY, Wang HB, Yang MX, Sheng ZY. The effect of valproic acid in alleviating early death in burn shock. Burns 2012;38:83–89.
Thomas SJ, Kramer GC, Herndon DN. Burns: military options and tactical solutions. J Trauma 2003;54:S207–S218.
Wang Q, Yao YM, Wang WJ, Xian LM, Dong N, Xu S, et al. Effect of Xuebijing Injection on renal high mobility group box-1 protein expression and acute kidney injury in rats after scald injury. Acta Acad Med Sin (Chin) 2007;29:478–483.
Gao YL, Chai YF, Yao YM. Advancement in the research of mechanism of immune dysfunction in sepsis and the regulatory effects of Xuebijing Injection. Chin J Burns (Chin) 2013;29:162–165.
Wang YB, Wang Q, Yao YM, Sheng ZY, Liu YF. Effect of Xuebijing Injection on systemic lupus erythematosus in mice. Chin J integr Med 2013;19:675–682.
Cancio LC, Kramer GC, Hoskins SL. Gastrointestinal fluid resuscitation of thermally injured patients. J Burn Care Res 2006;27:561–569.
Huang QB. Relationship between the endothelial barrier and vascular permeability after burns and its mechanism. Chin J Burns (Chin) 2007;23:324–326.
Li YZ, Liu XH, Rong F, Hu S, Sheng ZY. Carbachol inhibits TNF-α-induced endothelial barrier dysfunction through alpha 7 nicotinic receptors. Acta Pharmacol Sin 2010;31:1389–1394.
Seynhaeve AL, Vermeulen CE, Eggermont AM, ten Hagen TL. Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells. Cell Biochem Biophys 2006;44:157–169.
Xuebijing Injection (血必净注射液) and Resolvin D1 Synergize Regulate Leukocyte Adhesion and Improve Survival Rate in Mice with Sepsis-Induced Lung Injury
Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture
Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients
Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome
Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats
相关作者
暂无数据
相关机构
Department of Cell and Molecular Biology, Institute of Acute Abdominal Diseases of Intergrated Traditional Chinese and Western Medicine, Tianjin Nankai Hospital
Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School
Department of Surgery, Tianjin Nankai Hospital
Georg-August-Universität Göttingen, Göttingen
The Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics’ Ministry of Public Health